Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alkaline phosphatase for ICU-admitted COVID-19 patients with acute respiratory insufficiency
NL-OMON22695Not yet recruiting
- Sponsor
- Rode Kruis Ziekenhuis
- Start
- Jul 2020
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of bovine intestinal alkaline phosphatase in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Rode Kruis Ziekenhuis. Primary endpoint: Duration of mechanical ventilation. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON22695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22695.